Isabella Sudano
Overview
Explore the profile of Isabella Sudano including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
124
Citations
1622
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Camafort M, Kasiakogias A, Agabiti-Rosei E, Masi S, Iliakis P, Benetos A, et al.
Eur J Intern Med
. 2025 Feb;
PMID: 39955235
Appropriate management of older people with hypertension is essential to reduce the burden of hypertensive heart disease and further cardiovascular sequelae but there may be challenges given the presence of...
2.
Laptseva N, Bitos K, Rossi V, Nebunu D, Haider T, Nagele M, et al.
Microvasc Res
. 2024 Dec;
158:104780.
PMID: 39708913
Background And Aims: Systemic sclerosis (SSc) is a systemic autoimmune disease, characterized by widespread microvasculopathy and fibrosis. Vascular and endothelial cell changes appear to precede other features of SSc. Retinal...
3.
Nagele M, Haider T, Kreysing L, Barthelmes J, Nebunu D, Rossi V, et al.
JACC Adv
. 2024 Nov;
3(12):101392.
PMID: 39606217
Background: The mechanism of how sacubitril/valsartan improves outcomes in heart failure with reduced ejection fraction (HFrEF) is still incompletely understood. Objectives: The aim of this trial was to delineate the...
4.
Rossi V, Nebunu D, Nagele M, Barthelmes J, Haider T, Laptseva N, et al.
Clin Res Cardiol
. 2024 Aug;
PMID: 39167193
Background: A significant proportion of patients with heart failure (HF) progress to an advanced stage, which is associated with a substantial increase in morbidity and mortality. These patients may be...
5.
Halimi J, Sarafidis P, Azizi M, Bilo G, Burkard T, Bursztyn M, et al.
Blood Press
. 2024 Jun;
33(1):2368800.
PMID: 38910347
Objective Real-life management of patients with hypertension and chronic kidney disease (CKD) among European Society of Hypertension Excellence Centres (ESH-ECs) is unclear : we aimed to investigate it. Methods A...
6.
Rosemann T, Sudano I, Luscher T, Strehle O, Senn O
Praxis (Bern 1994)
. 2024 Jun;
113(5):113-118.
PMID: 38864104
There is potential for improvement in the care of cardiovascular diseases in Switzerland, particularly when it comes to achieving target values defined in guidelines. Adherence scores such as the SGED...
7.
Halimi J, Sarafidis P, Azizi M, Bilo G, Burkard T, Bursztyn M, et al.
J Hypertens
. 2024 May;
42(9):1544-1554.
PMID: 38747416
Objective: Real-life management of hypertensive patients with chronic kidney disease (CKD) is unclear. Methods: A survey was conducted in 2023 by the European Society of Hypertension (ESH) to assess management...
8.
Romanens M, Adams A, Wenger M, Warmuth W, Sudano I
Swiss Med Wkly
. 2024 Apr;
154:3735.
PMID: 38579303
Aims: Many cardiovascular events occur in seemingly healthy individuals.We set out to assess the predictive value of atherosclerosis imaging in combination with cardiovascular risk calculators in subjects aged 40-65 years....
9.
10.
Sudano I, Krahenbuhl S, Mach F, Anstett A, Dhalwani N, Bridges I, et al.
Ther Adv Cardiovasc Dis
. 2024 Jan;
18:17539447231213288.
PMID: 38183273
Aims: The HEYMANS study observed patients receiving evolocumab as part of routine clinical hyperlipidemia management. It was designed to capture data on clinical parameters relevant to health authorities and physicians....